Mifepristone
|
Product Name |
|||||
|
Synonyms |
11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-estra-9-dien-3-one;11beta-[4-(n,n-dimethylamino)phenyl]-17alpha-(prop-1-ynyl)-delta4,9-estradiene;17-beta)-(11-bet;17beta)-11-[4-(dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl)estra-(11bet;17-beta-hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oest;-17beta-ol-3-one;4,9-dien-3-one;r38486 |
||||
|
CAS |
|||||
|
Molecular formula |
C29H35NO2 |
||||
|
Molecular Weight |
429.59 |
||||
|
Molecular Structure |
 |
||||
|
Physical and Chemical Properties |
|
||||
|
Usage |
a synthetic, steroidal antiprogestogen and antiglucocorticoid drug |
||||
|
Specifications |
|||||
|
Test |
Standard |
||||
|
Description |
Light Yellowish Crystalline Powder |
||||
|
Identification |
(1)304nm,260nm |
||||
|
Melting Point |
192~196℃ |
||||
|
Specific Rotation |
+124°~+129° |
||||
|
(HPLC) Related substances |
(1)(single):≤0.5% |
||||
|
(1)(Total):≤1.0% |
|||||
|
Loss On Drying |
≤0.5% |
||||
|
Assay |
≥98.5% |
||||
|
Sieve analysis |
≤30μm |
||||
